ArticleAdvances in therapy2025

Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study.

Axel S Merseburger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.